S. 1562 (119th)Bill Overview

PREEMIE Reauthorization Act of 2025

Health|Health
Cosponsors
Support
Bipartisan
Introduced
May 1, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill reauthorizes the PREEMIE program through fiscal years 2025–2029 and makes a technical correction to prior law. It requires the HHS Secretary to establish an interagency working group within 18 months.

Why people may split

Left emphasizes equity, implementation funding, and community input.

Watch point

Relative to its intended legislative type, this bill is principally a study/commission/reporting vehicle with explicit deliverables and timelines, and also contains targeted statutory amendments to an existing program.

The bill reauthorizes the PREEMIE program through fiscal years 2025–2029 and makes a technical correction to prior law.

It requires the HHS Secretary to establish an interagency working group within 18 months.

HHS must contract with the National Academies to convene a maternal health expert committee within 30 days to study premature births and produce a consensus report within 24 months.

Passage75/100

Narrow, noncontroversial reauthorization with modest fiscal implications and concrete implementation steps increases prospects; final outcome depends on appropriations and legislative calendar.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is principally a study/commission/reporting vehicle with explicit deliverables and timelines, and also contains targeted statutory amendments to an existing program. It provides clear mechanism-level detail (responsible actors, deadlines, and required report contents) but omits funding authorization and several operational safeguards.

Contention50/100

Left emphasizes equity, implementation funding, and community input.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesContinues federal legal authorization for prematurity research and education activities through 2029.
  • Federal agenciesRequires an interagency group likely to improve federal coordination on maternal and infant health efforts.
  • Potential benefitA National Academies study will produce comprehensive cost estimates to inform policy and budget choices.
Likely burdened
  • Potential burdenMandates create additional administrative burdens and costs for HHS to establish the working group and study.
  • Potential burdenThe bill requires actions that may need appropriations, but it does not designate specific funding.
  • Potential burdenRaw data reporting could raise privacy, data-sharing, or compliance burdens for agencies and providers.
03 · Why people split

Why the argument around this bill splits.

Left emphasizes equity, implementation funding, and community input.
Progressive85%

Likely supportive overall because the bill expands research, data transparency, and public health analysis on prematurity.

Views the National Academies study and required analyses as useful for addressing disparities and improving maternal-infant health.

May criticize absence of explicit funding and push for equity and community-engagement provisions.

Leans supportive
Centrist75%

Generally favorable because the bill uses an evidence-driven approach and third-party assessment (National Academies).

Appreciates interagency coordination and the emphasis on costs and best practices.

Wants clearer funding, measurable outcomes, and avoidance of duplicative federal programs.

Leans supportive
Conservative40%

Mixed to skeptical: supports research into infant health but worries about federal overreach, new bureaucracy, and potential costs.

Concerned the 'shall establish' interagency mandate could expand federal activity without congressional appropriations.

Prefers state-led solutions, private-sector innovation, and protections for data privacy.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood75/100

Narrow, noncontroversial reauthorization with modest fiscal implications and concrete implementation steps increases prospects; final outcome depends on appropriations and legislative calendar.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No explicit appropriation or cost estimate included
  • National Academies capacity to meet 30-day/24-month deadlines
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Left emphasizes equity, implementation funding, and community input.

Narrow, noncontroversial reauthorization with modest fiscal implications and concrete implementation steps increases prospects; final outco…

Unlocked analysis

Relative to its intended legislative type, this bill is principally a study/commission/reporting vehicle with explicit deliverables and timelines, and also contains targeted statutory amendments to an existing program.…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis